ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 225 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q3 2014. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $423,533 | -27.1% | 40,375 | -8.7% | 0.00% | -40.0% |
Q3 2023 | $581,366 | +11.1% | 44,244 | +6.5% | 0.01% | +25.0% |
Q2 2023 | $523,252 | +172.7% | 41,528 | +182.4% | 0.00% | +100.0% |
Q1 2023 | $191,900 | -32.1% | 14,705 | -8.2% | 0.00% | 0.0% |
Q4 2022 | $282,522 | +9.5% | 16,016 | +15.0% | 0.00% | 0.0% |
Q2 2021 | $258,000 | +12.2% | 13,922 | -9.1% | 0.00% | 0.0% |
Q1 2021 | $230,000 | -42.4% | 15,314 | -44.6% | 0.00% | -33.3% |
Q4 2020 | $399,000 | -51.7% | 27,635 | -52.3% | 0.00% | -40.0% |
Q3 2018 | $826,000 | +8.8% | 57,987 | -8.1% | 0.01% | 0.0% |
Q2 2018 | $759,000 | -11.7% | 63,113 | -9.3% | 0.01% | +150.0% |
Q1 2018 | $860,000 | -5.9% | 69,606 | +11.0% | 0.00% | 0.0% |
Q4 2017 | $914,000 | -23.2% | 62,704 | -25.1% | 0.00% | -33.3% |
Q3 2017 | $1,190,000 | +22.2% | 83,663 | +9.6% | 0.00% | 0.0% |
Q2 2017 | $974,000 | +27.5% | 76,345 | +26.9% | 0.00% | +50.0% |
Q1 2017 | $764,000 | -50.0% | 60,182 | -59.8% | 0.00% | -50.0% |
Q4 2016 | $1,529,000 | -19.1% | 149,708 | +4.4% | 0.00% | -33.3% |
Q3 2016 | $1,889,000 | +35.9% | 143,407 | +31.0% | 0.01% | +50.0% |
Q2 2016 | $1,390,000 | +37.1% | 109,436 | +42.6% | 0.00% | +33.3% |
Q1 2016 | $1,014,000 | -20.0% | 76,741 | -6.9% | 0.00% | -25.0% |
Q4 2015 | $1,268,000 | +34.0% | 82,414 | +8.0% | 0.00% | +33.3% |
Q3 2015 | $946,000 | -37.3% | 76,303 | -30.8% | 0.00% | -25.0% |
Q2 2015 | $1,509,000 | +17.9% | 110,281 | +3.1% | 0.00% | +33.3% |
Q1 2015 | $1,280,000 | -94.1% | 107,010 | -93.7% | 0.00% | -94.4% |
Q4 2014 | $21,556,000 | -12.0% | 1,688,017 | -7.6% | 0.05% | -8.5% |
Q3 2014 | $24,509,000 | +836.9% | 1,826,954 | +1021.1% | 0.06% | +742.9% |
Q2 2014 | $2,616,000 | +158.0% | 162,965 | +189.9% | 0.01% | +133.3% |
Q1 2014 | $1,014,000 | +24.1% | 56,219 | +6.3% | 0.00% | +50.0% |
Q4 2013 | $817,000 | +266.4% | 52,876 | +253.0% | 0.00% | +100.0% |
Q3 2013 | $223,000 | -80.0% | 14,977 | -82.6% | 0.00% | -80.0% |
Q2 2013 | $1,116,000 | – | 86,292 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthCor Management, L.P. | 11,000,000 | $163,570,000 | 8.77% |
Blue Harbour Group | 7,262,346 | $107,991,000 | 8.08% |
RIVULET CAPITAL, LLC | 265,000 | $3,941,000 | 4.12% |
Breithorn Capital Management | 336,760 | $5,008,000 | 2.92% |
EMINENCE CAPITAL, LP | 7,791,132 | $115,854,000 | 2.56% |
Chinook Capital Management | 76,275 | $1,134,000 | 1.73% |
GARGOYLE INVESTMENT ADVISOR L.L.C. | 198,008 | $2,657,000 | 1.64% |
Adirondack Research & Management Inc. | 190,749 | $2,836,000 | 1.63% |
INTREPID CAPITAL MANAGEMENT INC /DE/ | 100,000 | $1,487,000 | 1.05% |
PRICE MICHAEL F | 477,500 | $7,100,000 | 0.94% |